444 followers
Casticin inhibits nasopharyngeal carcinoma growth by targeting phosphoinositide 3-kinase. https://t.co/9f8gHJtNHH https://t.co/gS5tYol1gG
Casticin inhibits nasopharyngeal carcinoma growth by targeting phosphoinositide 3-kinase. https://t.co/9f8gHJtNHH https://t.co/gS5tYol1gG
Casticin is a newly emerging selective PI3K inhibitor with potential for use as a targeted therapeutic treatment for nasopharyngeal carcinoma. https://t.co/XG8oYeiaMX